Business Description
Namwiwat Medical Corp PCL
ISIN : THB663010007
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.16 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 1.24 | |||||
Interest Coverage | 15.39 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 5.7 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate | 8.48 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.43 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.43 | |||||
9-Day RSI | 64.75 | |||||
14-Day RSI | 59.26 | |||||
6-1 Month Momentum % | -3.46 | |||||
12-1 Month Momentum % | -16.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.09 | |||||
Quick Ratio | 4 | |||||
Cash Ratio | 2.66 | |||||
Days Inventory | 327.4 | |||||
Days Sales Outstanding | 185.89 | |||||
Days Payable | 47.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.91 | |||||
Dividend Payout Ratio | 0.26 | |||||
Forward Dividend Yield % | 1.91 | |||||
5-Year Yield-on-Cost % | 1.91 | |||||
Shareholder Yield % | 1.98 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.12 | |||||
Operating Margin % | 18.98 | |||||
Net Margin % | 16.7 | |||||
FCF Margin % | -3.86 | |||||
ROE % | 6.28 | |||||
ROA % | 5.25 | |||||
ROIC % | 8.95 | |||||
ROC (Joel Greenblatt) % | 15.51 | |||||
ROCE % | 8.03 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 12.63 | |||||
Forward PE Ratio | 13.82 | |||||
PE Ratio without NRI | 13.7 | |||||
PS Ratio | 4.42 | |||||
PB Ratio | 1.62 | |||||
Price-to-Tangible-Book | 1.68 | |||||
Price-to-Operating-Cash-Flow | 104.45 | |||||
EV-to-EBIT | 15.18 | |||||
EV-to-EBITDA | 13.07 | |||||
EV-to-Revenue | 3.4 | |||||
EV-to-FCF | -84.27 | |||||
Price-to-Graham-Number | 1.01 | |||||
Price-to-Net-Current-Asset-Value | 2.25 | |||||
Price-to-Net-Cash | 6.03 | |||||
Earnings Yield (Greenblatt) % | 6.6 | |||||
FCF Yield % | -0.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Namwiwat Medical Corp PCL Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ฿) | 743.741 | ||
EPS (TTM) (฿) | 0.372 | ||
Beta | 0 | ||
Volatility % | 36.58 | ||
14-Day RSI | 59.26 | ||
14-Day ATR (฿) | 0.098414 | ||
20-Day SMA (฿) | 4.57 | ||
12-1 Month Momentum % | -16.64 | ||
52-Week Range (฿) | 4.34 - 7.5 | ||
Shares Outstanding (Mil) | 700 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Namwiwat Medical Corp PCL Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Namwiwat Medical Corp PCL Stock Events
Event | Date | Price(฿) | ||
---|---|---|---|---|
No Event Data |
Namwiwat Medical Corp PCL Frequently Asked Questions
What is Namwiwat Medical Corp PCL(BKK:NAM)'s stock price today?
When is next earnings date of Namwiwat Medical Corp PCL(BKK:NAM)?
Does Namwiwat Medical Corp PCL(BKK:NAM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |